HAKE RESHMA PAPPU, BORKAR GAYATRI BHANUDAS, TAMHANE SIDDHI DATTATRAY, KARANDE PRATIKSHA BARIKRAO

With its ability to identify pharmaceutical substances and their metabolites quickly, sensitively, and in real time, biosensors have become a potent analytical tool for drug monitoring. In order to translate biochemical interactions into quantifiable signals, these devices combine a transducer with a biological recognition factor, such as enzymes, antibodies, or nucleic acids. Biosensors offer accurate detection of medication concentrations in biological fluids in therapeutic drug monitoring, supporting individualized treatment and maximizing dosing regimes while reducing toxicity and adverse effects. The performance, portability, and cost of biosensors have been greatly improved by recent developments in nanotechnology and microfabrication, making their use in point-of-care testing easier. Biosensors have great potential to improve clinical outcomes and streamline medication monitoring procedures in healthcare settings, despite issues with stability, selectivity, and standardization.